CPWM LLC’s PhenomeX Inc. Common Stock CELL Stock Holding History

CPWM LLC’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13,420	Closed	-$95K	–	412
2022 Q1	$95K	Buy	+13,420	New	+$111K	0.01%	337

Other funds holding CELL

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CPWM LLC's CELL Position: Q2 2022 in Review

CPWM LLC sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 13,420 shares — an estimated $95K sold.

CPWM LLC first reported a position in CELL in Q1 2022 and held it in 1 quarter. The position peaked at $95K in Q1 2022. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

CPWM LLC reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
CPWM LLC sold 13,420 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $95K.
CPWM LLC first reported a position in PhenomeX Inc. Common Stock in Q1 2022 and held it in 1 quarter.
CPWM LLC's PhenomeX Inc. Common Stock position peaked at $95K in Q1 2022.
123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on CPWM LLC's 13F filing for Q2 2022, filed 12 Aug 2022.